Perrigo Company PLC (PRGO) - Total Assets
Based on the latest financial reports, Perrigo Company PLC (PRGO) holds total assets worth $7.98 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check PRGO total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Perrigo Company PLC - Total Assets Trend (1991–2025)
This chart illustrates how Perrigo Company PLC's total assets have evolved over time, based on quarterly financial data. Explore PRGO long-term investment intensity to see how much of total assets are deployed in long-term investments.
Perrigo Company PLC - Asset Composition Analysis
Current Asset Composition (December 2025)
Perrigo Company PLC's total assets of $7.98 Billion consist of 32.8% current assets and 67.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.2% |
| Accounts Receivable | $612.80 Million | 7.2% |
| Inventory | $1.15 Billion | 13.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.35 Billion | 27.6% |
| Goodwill | $2.05 Billion | 24.0% |
Asset Composition Trend (1991–2025)
This chart illustrates how Perrigo Company PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Perrigo Company PLC (PRGO) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Perrigo Company PLC's current assets represent 32.8% of total assets in 2025, a decrease from 51.6% in 1991.
- Cash Position: Cash and equivalents constituted 6.2% of total assets in 2025, up from 0.2% in 1991.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 51.0% of total assets, an increase from 0.0% in 1991.
- Asset Diversification: The largest asset category is intangible assets at 27.6% of total assets.
Perrigo Company PLC Competitors by Total Assets
Key competitors of Perrigo Company PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA
|
India | Rs585.02 Billion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
|
China | CN¥10.37 Billion |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
China | CN¥7.28 Billion |
|
Xeris Pharmaceuticals Inc
NASDAQ:XERS
|
USA | $392.01 Million |
|
Procter & Gamble Health Limited
NSE:PGHL
|
India | Rs8.94 Billion |
Perrigo Company PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 2.36 | 2.23 |
| Quick Ratio | 1.59 | 1.28 | 1.67 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.71 Billion | $1.46 Billion | $2.44 Billion |
Perrigo Company PLC - Advanced Valuation Insights
This section examines the relationship between Perrigo Company PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.68 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | -11.5% |
| Total Assets | $8.54 Billion |
| Market Capitalization | $1.48 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Perrigo Company PLC's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Perrigo Company PLC's assets decreased by 11.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Perrigo Company PLC (1991–2025)
The table below shows the annual total assets of Perrigo Company PLC from 1991 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $8.54 Billion | -11.53% |
| 2024-12-31 | $9.65 Billion | -10.74% |
| 2023-12-31 | $10.81 Billion | -1.89% |
| 2022-12-31 | $11.02 Billion | +5.67% |
| 2021-12-31 | $10.43 Billion | -9.25% |
| 2020-12-31 | $11.49 Billion | +1.65% |
| 2019-12-31 | $11.30 Billion | +2.90% |
| 2018-12-31 | $10.98 Billion | -5.55% |
| 2017-12-31 | $11.63 Billion | -16.16% |
| 2016-12-31 | $13.87 Billion | -28.48% |
| 2015-12-31 | $19.39 Billion | +39.72% |
| 2014-12-31 | $13.88 Billion | +0.20% |
| 2013-12-31 | $13.85 Billion | +158.90% |
| 2012-12-31 | $5.35 Billion | +32.97% |
| 2011-12-31 | $4.02 Billion | +26.18% |
| 2010-12-31 | $3.19 Billion | +3.12% |
| 2009-12-31 | $3.09 Billion | +21.94% |
| 2008-12-31 | $2.54 Billion | -1.50% |
| 2007-12-31 | $2.58 Billion | +33.76% |
| 2006-12-31 | $1.93 Billion | +9.97% |
| 2005-12-31 | $1.75 Billion | +2.68% |
| 2004-12-31 | $1.70 Billion | +124.61% |
| 2003-12-31 | $759.09 Million | +17.88% |
| 2002-12-31 | $643.97 Million | +8.45% |
| 2001-12-31 | $593.79 Million | +3.10% |
| 2000-12-31 | $575.91 Million | +10.54% |
| 1999-12-31 | $521.02 Million | -10.43% |
| 1998-12-31 | $581.70 Million | -2.38% |
| 1997-12-31 | $595.90 Million | -7.06% |
| 1996-12-31 | $641.20 Million | +16.71% |
| 1995-12-31 | $549.40 Million | -1.13% |
| 1994-12-31 | $555.70 Million | +9.50% |
| 1993-12-31 | $507.50 Million | +22.67% |
| 1992-12-31 | $413.70 Million | +30.55% |
| 1991-12-31 | $316.90 Million | -- |
About Perrigo Company PLC
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and ora… Read more